Foundation Medicine utilizes advanced genomic sequencing technologies to analyze a patient’s tumor DNA. The process begins with a biopsy, where a sample of the tumor is collected. This sample is then sequenced to identify genetic mutations, genomic alterations, and other molecular changes that are driving the cancer's growth. The results are compiled into a comprehensive report that can be used by oncologists to tailor treatments based on the genetic profile of the cancer.
